ARCA:PBE

Invesco Biotechnology & Genome ETF

$ 89.6886 1.5769 ( +1.79%) 03:57 PM EST
PE Ratio:
19.89
PB Ratio:
3.75
Volume:
14.66K
Dividend Yield %:
1.5
Last Holding update 2026-06-26 30 Stocks (3 new)
Value $248.00 Mil Turnover 12 %
Registrant: Invesco Biotechnology & Genome ETF
Year: 2026
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

GuruFocus Rankings

Financial Strength
7 /10
Profitability Rank
6 /10
GF Value Rank
6 /10
Growth Rank
7 /10
Momentum Rank
6 /10

Invesco Biotechnology & Genome ETF Geographic Breakdown

Invesco Biotechnology & Genome ETF Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017

Invesco Biotechnology & Genome ETF Key Statistics

Name Value
Day's Open ($) 88.12
Day's Range ($) 88.12 - 90.33
Day's Volume 14,656
52-Week Range ($) 63.6847 - 90.33
Beta 0.7988
3-Year Sharpe Ratio 0.48
3-Year Sortino Ratio 0.84
Volatility 14.07
14-Day RSI 73.22
14-Day ATR ($) 1.437724
20-Day SMA ($) 84.50046

Fundamental Data

Name Value
Market Cap (Mil $) 277.138
Shares Outstanding (Mil) 3.09
PE Ratio 19.89
PE Ratio (10y Range) -
PE Ratio (10y Median) -
PB Ratio 3.75
PB Ratio (10y Range) -
PB Ratio (10y Median) -

Dividend Data

Name Value
Dividends per Share (TTM) ($) -
Dividend Yield % 1.5
Dividend Yield % (10y Range) -
Dividend Yield % (10y Median) -
Next Dividend Payment Date
Dividend Frequency Quarterly

PBE Invesco Biotechnology & Genome ETF Fundamental Charts

Historical TTM Price-to-Earnings for PBE Invesco Biotechnology & Genome ETF

Historical TTM Price-to-Earnings without NRI for PBE Invesco Biotechnology & Genome ETF

Historical Price-to-Book Ratio for PBE Invesco Biotechnology & Genome ETF

Historical Dividend Yields for PBE Invesco Biotechnology & Genome ETF

Invesco Biotechnology & Genome ETF Technical Indicators

Moving Average

Momentum

Gurus Latest Trades with ARCA:PBE

No Available Data

ARCA:PBE is held by these investors

No Available Data
Invesco Biotechnology & Genome... Top Holdings of 2026-04-30 View Full List
Ticker
Company
Shares
Value ($1000)
Shares Change %
Weighting %
Trade Impact %
% of Shares outstanding
3M Change %
YTD Change %
Market Cap $Mil
Industry
UTHR
United Therapeutics Corp
27,212
15,547.6
-0.11%
6.280
-0.01%
0.060
+1.83%
+11.29%
23,018.0
Drug Manufacturers
ILMN
Illumina Inc
104,832
13,286.4
+1.58%
5.370
+0.08%
0.070
+41.92%
+34.61%
26,712.0
Medical Diagnostics & Research
BIIB
Biogen Inc
66,025
12,497.2
-10.19%
5.050
-0.51%
0.040
+13.07%
+22.75%
31,894.0
Drug Manufacturers
INCY
Incyte Corp
127,499
12,146.8
+4.20%
4.910
+0.20%
0.060
+23.30%
+15.18%
22,727.2
Biotechnology
ALNY
Alnylam Pharmaceuticals Inc
38,706
11,979.1
+29.30%
4.840
+1.10%
0.030
-11.21%
-26.73%
38,901.6
Biotechnology
REGN
Regeneron Pharmaceuticals Inc
16,684
11,796.6
-2.27%
4.770
-0.11%
0.020
-16.24%
-17.78%
66,352.6
Biotechnology
AMGN
Amgen Inc
33,651
11,651.7
-13.46%
4.710
-0.68%
0.010
+2.23%
+11.07%
193,393.7
Drug Manufacturers
GILD
Gilead Sciences Inc
87,264
11,417.6
-15.91%
4.610
-0.89%
0.010
-5.96%
+5.47%
158,772.0
Drug Manufacturers
BCRX
BioCryst Pharmaceuticals Inc
923,458
8,458.9
-11.05%
3.420
-0.29%
0.360
+4.29%
+27.82%
2,534.0
Drug Manufacturers
CPRX
Catalyst Pharmaceuticals Inc
290,513
8,172.1
-3.68%
3.300
-0.10%
0.240
+29.90%
+34.96%
3,856.2
Biotechnology

Invesco Biotechnology & Genome ETF's Historical Top Holdings Breakdowns

Invesco Biotechnology & Genome ETF's Top Stock Picks View Full List
Ticker
Company
Date
Action
Impact %
Price Range
Price
Price Change from Avrg%
Comment
Current Shares
Share Change
FOLD Unlock Delisted
Amicus Therapeutics Inc
2026-04-30
Sold Out
Sold Out
-3.90%
14.27 ($14.39) 14.49
$14.49
0.69%
Sold Out
0
-716,939
DVAX Unlock Delisted
Dynavax Technologies Corp
2026-04-30
Sold Out
Sold Out
-3.65%
15.48 ($15.5) 15.51
$15.50
0%
Sold Out
0
-619,803
ARWR
Arrowhead Pharmaceuticals Inc
2026-04-30
New Buy
New Buy
+3.28%
55.01 ($63.87) 74.4
$79.03
23.74%
New holding
110,374
110,374
CDNA
CareDx Inc
2026-04-30
New Buy
New Buy
+3.07%
16.05 ($18.77) 22.42
$28.76
53.22%
New holding
365,065
365,065
TBPH
Theravance Biopharma Inc
2026-04-30
New Buy
New Buy
+2.49%
13.57 ($16.7) 20.48
$17.64
5.63%
New holding
368,704
368,704
MDGL
Madrigal Pharmaceuticals Inc
2026-04-30
Sold Out
Sold Out
-2.24%
425.85 ($480.7) 546.89
$512.65
6.65%
Sold Out
0
-12,061
ALNY
Alnylam Pharmaceuticals Inc
2026-04-30
Add
Add
+1.10%
301.19 ($322.29) 351.96
$291.37
-9.59%
Add 29.3%
38,706
8,770
GILD
Gilead Sciences Inc
2026-04-30
Reduce
Reduce
-0.89%
127.75 ($142.58) 155.8
$127.88
-10.31%
Reduce -15.91%
87,264
-16,506
AMGN
Amgen Inc
2026-04-30
Reduce
Reduce
-0.68%
338.02 ($360.13) 388.16
$358.33
-0.50%
Reduce -13.46%
33,651
-5,234
VCYT
Veracyte Inc
2026-04-30
Add
Add
+0.60%
30.01 ($34.02) 38.75
$60.38
77.48%
Add 29.68%
196,903
45,071

Invesco Biotechnology & Genome ETF Total Holding History ($B)

To

Invesco Biotechnology & Genome ETF's Asset Allocation

To

Invesco Biotechnology & Genome ETF Past Portfolios

Portfolio Date Number of Stocks New Stocks Total Value ($Mil) Q/Q Turnover

Top Ranked Articles

  • 1

Invesco Biotechnology & Genome ETF's Hypothetical Growth since 2026-04-30

Invesco Biotechnology & Genome ETF's Yearly Returns

This information is only displayed for Gurus who publicly disclose audited performance records; most hedge funds and private investment firms do not publish such data or only provide limited historical performance information.

Year Portfolio % % Excess Gain %

Invesco Biotechnology & Genome ETF's Holdings Heat Map

Size field:

Invesco Biotechnology & Genome ETF's Holdings Bubble Chart

Discussions on Invesco Biotechnology & Genome ETF

User's Avatar
How would you rate this stock? PBE
No discussions yet.